Spliceosome-targeted Therapies in Triple-Negative Breast Cancer treatment
Sayak Banerjee, Amity University Kolkata According to the scientists at Baylor College of Medicine, antiviral immune pathways in triple-negative breast cancers (TNBC) can be activated by therapeutics targeting RNA splicing along with the stimulation of tumour cell death. Around 10-20% of breast cancers are triple-negative, which signifies that they are negative not only for estrogen […]